TippingPoint Biosciences
Latest round
- Seed
Last raised
- Mar 2026
Total raised
- $4.5M
Investors
- 9
About TippingPoint Biosciences
Founded in 2022 and based in California, US, TippingPoint Biosciences, Inc. is a therapeutic company that provides a drug discovery platform focused on developing treatments for diseases caused by DNA defects. Laura Hsieh (CEO) and Geeta J. Narlikar are the co-founders of the company. In March 2026, TippingPoint Biosciences, Inc. The company focuses on therapies for diseases driven by dysfunctional chromatin networks. TippingPoint's approach targets diseases that arise from chromatin dysfunction, such as pediatric diffuse midline glioma (DMG), a condition that has proven challenging to treat with therapies. The firm has developed a method to replicate disease-causing chromatin interactions in a controlled environment, allowing them to target these aberrant networks.
Who invested in TippingPoint Biosciences
9 investors across 1 round
See all investors in TippingPoint Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 31, 2026
Amount
$4.5M
Investors
Questions about TippingPoint Biosciences
Who invested in TippingPoint Biosciences?
TippingPoint Biosciences has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TippingPoint Biosciences raised?
TippingPoint Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TippingPoint Biosciences last raise money?
TippingPoint Biosciences's most recent round on record is a Seed, in Mar 2026.
What does TippingPoint Biosciences do?
Founded in 2022 and based in California, US, TippingPoint Biosciences, Inc.
Where is TippingPoint Biosciences headquartered?
TippingPoint Biosciences is headquartered in San Francisco, US.
Which VCs invest in companies like TippingPoint Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TippingPoint Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like TippingPoint Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.